We are live on ! Find out more
HSG Holding

HSG Holding Portfolio holdings

AUM $1.2B Turnover 9.52%
1-Year Est. Return 23.01%
This Fund
S&P 500
This Quarter Est. Return
-21.96%
1 Year Est. Return
-23.01%
3 Year Est. Return
-2.73%
5 Year Est. Return
-65.27%
10 Year Est. Return
+636%
AUM
$1.2B
AUM Growth
-$423M
Cap. Flow
-$29.7M
Cap. Flow %
-2.48%
Top 10 Hldgs %
97.2%
Holding
21
New
1
Increased
–
Reduced
–
Closed
1
Avg Time Held
4 years
Top 10 Avg Time Held
2.9 years
Top 20 Avg Time Held
3.9 years

Top Buys

Rank Stock Value
1
GYRE icon
Gyre Therapeutics
GYRE
+$25.5M

Top Sells

Rank Stock Value
1
BULL icon
Webull Corp
BULL
+$55.2M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 73.25%
2 Financials 9.3%
3 Healthcare 5.93%
4 Technology 4.87%
5 Real Estate 2.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PDD icon
1
Pinduoduo
PDD
$115B
$866M 72.31%
11,348,426
– –
2018 Q3
31 quarters
FUTU icon
2
Futu Holdings
FUTU
$14.9B
$69.4M 5.8%
740,352
– –
2021 Q1
21 quarters
PONY icon
3
Pony AI Inc
PONY
$2.18B
$52.4M 4.38%
7,538,358
– –
2026 Q1
1 quarter
CRCL icon
4
Circle Internet Group
CRCL
$20.9B
$41.9M 3.5%
669,200
– –
2025 Q4
2 quarters
BEKE icon
5
KE Holdings
BEKE
$19.8B
$28.2M 2.35%
1,939,017
– –
2020 Q3
23 quarters
GYRE icon
6
Gyre Therapeutics
GYRE
$645M
$24.7M 2.06%
+3,750,299
New +$25.5M
2026 Q2
0 quarters
BZ icon
7
Kanzhun
BZ
$7.27B
$24.5M 2.04%
1,900,000
– –
2021 Q2
20 quarters
AVBP icon
8
ArriVent BioPharma
AVBP
$868M
$23M 1.93%
663,308
– –
2024 Q1
9 quarters
DDL icon
9
Dingdong
DDL
$461M
$19.5M 1.63%
10,091,839
– –
2022 Q1
17 quarters
GPCR icon
10
Structure Therapeutics
GPCR
$1.54B
$14.3M 1.19%
266,062
– –
2023 Q3
11 quarters
COE icon
11
51Talk Online Education Group
COE
$67.3M
$7.57M 0.63%
474,901
– –
2020 Q1
25 quarters
LOT icon
12
Lotus Technology
LOT
$361M
$5.66M 0.47%
4,834,099
– –
2024 Q3
7 quarters
ADAG icon
13
Adagene
ADAG
$145M
$5.64M 0.47%
1,343,364
– –
2021 Q3
19 quarters
THCH icon
14
TH International
THCH
$33.6M
$5.54M 0.46%
2,900,606
– –
2023 Q2
12 quarters
BTDR icon
15
Bitdeer Technologies
BTDR
$2.19B
$4.66M 0.39%
293,732
– –
2023 Q2
12 quarters
LYEL icon
16
Lyell Immunopharma
LYEL
$205M
$2.14M 0.18%
152,299
– –
2021 Q2
20 quarters
SLAI
17
DELISTED
SOLAI Ltd ADS
SLAI
$1.12M 0.09%
50,061
– –
2014 Q3
47 quarters
BRNS
18
DELISTED
Barinthus Biotherapeutics
BRNS
$938K 0.08%
1,420,473
– –
2022 Q2
16 quarters
BNR icon
19
Burning Rock Biotech
BNR
$128M
$178K 0.01%
21,212
– –
2020 Q2
24 quarters
YMT
20
Yimutian Inc
YMT
$300K
$122K 0.01%
14,342
– –
2026 Q1
1 quarter
BULL icon
21
Webull Corp
BULL
$3.22B
– –
-7,053,639
Closed -$55.2M –

Similar funds

HSG Holding's Q2 2026 Portfolio in Review

As of Q2 2026, HSG Holding held 21 positions worth $1.2B, down 26% from $1.62B the previous quarter. Its ten largest holdings account for 97% of the portfolio.

HSG Holding's Q2 2026 filing shows 1 new and 1 closed positions. Its largest new stake was Gyre Therapeutics: 3,750,299 shares worth $24.7M. The largest sale was Webull Corp, an estimated $55.2M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 73% of assets, up from 71% a quarter earlier, followed by Financials and Healthcare.

  • HSG Holding's largest Q2 2026 buy was Gyre Therapeutics: 3,750,299 shares worth $24.7M.
  • HSG Holding fully exited Webull Corp in Q2 2026, selling an estimated $55.2M.
  • HSG Holding's ten largest holdings make up 97% of its $1.2B portfolio in Q2 2026.
  • HSG Holding opened 1 new position and closed 1 in Q2 2026.
  • HSG Holding's portfolio value fell 26% quarter-over-quarter to $1.2B.

Based on HSG Holding's 13F filing for Q2 2026, filed 13 Aug 2026.